Ansh Labs

Ansh Labs was formed in 2010 by Mr. Gopal Savjani. Mr. Savjani is the President and CEO of Ansh Labs, and the former President and CEO of Diagnostic Systems Laboratories.

Our primary focus is clinical research and diagnostics in the following key areas:

Our objective is to bring niche high quality immunoassays to the market and to serve physicians and researchers in these fields.

Many of the markers we develop are novel and so very early in their lifecycle. There is a growing body of research that supports clinical diagnostic utility for the assays we have developed, and there is exciting putative research involving the biomarkers that are in our research and development pipeline. Some of the assays are still so new that they may not be recognized by select regulatory bodies as clinical in vitro diagnostic assays at the present time.

Additionally, we are experts in immunoassay development and can usually develop an immunoassay from immunogen to validated product in a very short time frame. We have monoclonal antibody development and screening expertise, and we are familiar with all immunoassay techniques for which we can optimize mAb pairings.

As of January 2019, Ansh Labs employed 28 persons globally with the majority in its facility located in Webster, Texas USA.

Suchen Sie nach Ansh Labs-Produkten

Ansh Labs-Produkte nach Produktkategorie

• 
  Antibodies
• 
  ELISA & Immunoassays
• 
  Instruments & Equipment
• 
  Other Assays & Kits
• 
  Peptides & Proteins
• 
  Reagents & Chemicals
• 
  Alle Produkte

Ansh Labs-Produkte nach Research Area

• 
  Cell Biology
• 
  Metabolism
• 
  Neuroscience
• 
  Oncology